Financial statements Abgbio
Balance sheet of Abgbio
Company age:
Age:
11 y. 9 m. 22 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of ABGBIO
|
Year
|
2020
|
2021
|
|---|---|---|
| Total assets | 11 042,25 | 18 430,76 |
| A. Fixed assets | 3 456,00 | 3 456,00 |
| B. Current assets | 7 586,25 | 14 974,76 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 11 042,25 | 18 430,76 |
| A. Equity | -1 293 177,28 | -1 298 514,98 |
| B. Liabilities and provisions for liabilities | 1 304 219,53 | 1 316 945,74 |
| I. Long-term liabilities | 0,00 | 0,00 |
| II. Short-term liabilities | 1 149 001,53 | 1 161 727,74 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.